Review Article

Deep Brain Stimulation in Parkinson’s Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms

Table 1

Summary of studies on PD patients implanted with PPN-DBS for gait and balance impairment.

StudyNumber of PatientsInclusion criteriaStudy designStimulation targetStimulation parametersOutcomesAdverse eventsComments

Mazzone et al. [39]2FoGOpen labelBilateral PPNBipolar; 10 HzIntraoperative improvement of UPDRS III scoreNRFirst human study to demonstrate the potential efficacy of PPN-DBS in PD

Plaha and Gill [40]2FoG, PI, and frequent fallsOpen labelBilateral PPNBipolar; 20–25 HzUPDRS improved by 53%; UPDRS III by 57%Certain stimulation frequencies can exacerbate gaitShort follow-up, 42 days for patient 1 and 16 days for patient 2

Stefani et al. [41]6FoG, 3 had “on” FoG, UPDRS-III > 70, and levodopa-induced dyskinesiasOpen labelBilateral STN and PPNBipolar; 25 Hz at PPNPPN stimulation showed more benefit on posture and gait items compared to STN stimulation; UPDRS III improved by 32%; axial symptoms (UPDRS 27–30) by 60%ParesthesiaTotal length of study was 6 months; noted decline in motor benefit; trend of improved UPDRS scores with both STN and PPN stimulation

Strafella et al. [42]1Advanced PD, FoG, PIOpen labelUnilateral PPN70 HzUPDRS improved by 19%, mainly in relation to gait, tremor, and bradykinesiaNRPET studies showed increased rCBF in different subcortical areas, most notably in the thalamus bilaterally

Ferraye et al. [43]6Severe FoG unresponsive to levodopa and STN stimulationDouble-blinded assessmentBilateral STN and PPNBipolar; 15–25 HzOnly FoG showed clear improvement; gait and PI scores did not improve; falls unrelated to FoG were unchanged in 5/6Seizure in 1 patient; stimulation frequency dependent oscillopsia; paresthesias; limb myoclonusThe total length of the study was 1 year; objective improvement of FoG in 2 patients

Moro et al. [44]6Age < 70, severe “off” FoG and PI; no dementiaDouble-blinded assessmentUnilateral PPNBipolar; chronic stimulation frequency of 67 HzImprovement in UPDRS item 13 (falling) by 75% at 3 and 12 monthsStimulation frequency dependent oscillopsia and paresthesiasFirst double-blinded study to investigate unilateral PPN stimulation; total study length was 1 year

Thevathasan et al. [45]11Severe FoG and PI, in addition to falls both in the “on” and “off” statesOpen labelBilateral PPN in 8 patients, bilateral PPN and ZI in 2 patients, and unilateral PPN and bilateral ZI in 1 patientBipolar; 20–35 HzImprovement in frequency of falls and gaitNRFollow-up 3–38 months

Thevathasan et al. [46]5Severe FoG and PI, in addition to falls persisting in the “on” stateOpen labelBilateral PPNMonopolar; 35 Hz; PPN target more caudal than previousImprovement in all by FoG and falls questionnaire at 3 months and 2 yearsStimulation frequency dependent decline in motor function and gait; oscillopsiaTotal study length was 2 years; assessments at 3 months and 2 years

Khan et al. [47]7PD patients with severe FoG, PI, falls during “on” and “off” statesOpen labelBilateral PPN, in combination with cZi stimulationBipolar; 60 Hz (PPN)Improvement in UPDRS III score (18.8%) and axial symptoms score (26.3%)Akinesia in 2 patientsFollow-up 12 months; similar benefit with ZI stimulation versus ZI and PPN “on”

Thevathasan et al. [48]7PI, severe FoG, and falls during “on” stateOpen label5 bilateral and 2 unilateralBipolar; 35 HzImprovement in freezing of gait questionnaire, turn task duration, and cadenceNRFirst study to directly compare unilateral versus bilateral stimulation; less robust result in unilateral PPN

Mazzone et al. [49]2824 patients had PD and 4 had PSPOpen labelBoth bilateral (6) and unilateral (22) PPNBipolar; unilateral (40 Hz) and bilateral (25 Hz)Improvement in UPDRS III score in “off” medication and “on” stimulationNoneThe largest and longest study of PPN DBS to date with a mean follow-up of 3.8 years; included patients from prior studies

FoG, freezing of gait; NR, not reported; PD, Parkinson’s disease; PET, positron emission tomography; PI, postural instability; PPN, pedunculopontine nucleus; PSP, progressive supranuclear palsy; rCBF, regional cerebral; STN, subthalamic nucleus; UPDRS, United Parkinson Disease Rating Scale; ZI, zona incerta.